Marijana Protić

495 total citations
33 papers, 222 citations indexed

About

Marijana Protić is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Marijana Protić has authored 33 papers receiving a total of 222 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Genetics, 22 papers in Epidemiology and 17 papers in Surgery. Recurrent topics in Marijana Protić's work include Inflammatory Bowel Disease (28 papers), Microscopic Colitis (21 papers) and Eosinophilic Esophagitis (9 papers). Marijana Protić is often cited by papers focused on Inflammatory Bowel Disease (28 papers), Microscopic Colitis (21 papers) and Eosinophilic Esophagitis (9 papers). Marijana Protić collaborates with scholars based in United States, Canada and Belgium. Marijana Protić's co-authors include Frank Seibold, Alain Schoepfer, Stephan R. Vavricka, Daniela Bojic, Zoran Radojičić, Christian Mottet, Gerhard Rogler, Petar Svorcan, Pascal Juillerat and Pascal Frei and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and World Journal of Gastroenterology.

In The Last Decade

Marijana Protić

31 papers receiving 215 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marijana Protić United States	8	160	138	56	36	23	33	222
David Choi United States	10	142 0.9×	107 0.8×	52 0.9×	44 1.2×	6 0.3×	43	237
Josh Korzenik United States	5	179 1.1×	112 0.8×	79 1.4×	60 1.7×	9 0.4×	7	325
P. Hindryckx Belgium	4	94 0.6×	96 0.7×	43 0.8×	33 0.9×	6 0.3×	4	152
Maja Ideström Sweden	5	188 1.2×	125 0.9×	85 1.5×	103 2.9×	6 0.3×	8	304
José María Huguet Spain	10	106 0.7×	89 0.6×	86 1.5×	61 1.7×	14 0.6×	30	276
José Lázaro Pérez‐Calle Spain	6	161 1.0×	116 0.8×	67 1.2×	126 3.5×	10 0.4×	9	274
Kindra Clark‐Snustad United States	7	170 1.1×	134 1.0×	46 0.8×	66 1.8×	3 0.1×	31	273
Samantha Zullow United States	5	80 0.5×	88 0.6×	57 1.0×	29 0.8×	7 0.3×	19	224
Kenneth A Baker Canada	5	271 1.7×	211 1.5×	118 2.1×	32 0.9×	4 0.2×	8	310
Anders Forss Sweden	8	141 0.9×	138 1.0×	78 1.4×	21 0.6×	4 0.2×	33	196

Countries citing papers authored by Marijana Protić

Since Specialization

Citations

This map shows the geographic impact of Marijana Protić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marijana Protić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marijana Protić more than expected).

Fields of papers citing papers by Marijana Protić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marijana Protić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marijana Protić. The network helps show where Marijana Protić may publish in the future.

Co-authorship network of co-authors of Marijana Protić

This figure shows the co-authorship network connecting the top 25 collaborators of Marijana Protić. A scholar is included among the top collaborators of Marijana Protić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marijana Protić. Marijana Protić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hibi∥, Toshifumi, Taku Kobayashi, Masaru Tanaka, et al.. (2025). Patient and Health Care Professional Perspectives on the Burden and Daily Life Impact of Ulcerative Colitis and Crohn’s Disease: Results from the Japanese CONFIDE Study. Advances in Therapy. 42(4). 1834–1859. 2 indexed citations

Vermeire, Séverine, Bruce E. Sands, G. D’Haens, et al.. (2025). DOP005 Long-term efficacy and safety of mirikizumab treatment for Crohn’s Disease: Results from the VIVID-2 open-label extension study. Journal of Crohn s and Colitis. 19(Supplement_1). i91–i93. 2 indexed citations

Jairath, Vipul, Geert D’Haens, Bruce E. Sands, et al.. (2025). Bowel Urgency in Crohn’s Disease: Effects of Mirikizumab in a Randomized Controlled Phase 3 Study. Clinical Gastroenterology and Hepatology. 24(2). 463–473.e5.

Travis, Simon, Tadakazu Hisamatsu, Monika Fischer, et al.. (2024). OP12 Mirikizumab improves fatigue, bowel urgency, and quality of life in patients with moderately to severely active Crohn’s Disease: Results from a phase 3 clinical trial. Journal of Crohn s and Colitis. 18(Supplement_1). i21–i23. 5 indexed citations

Atreya, Raja, et al.. (2024). Burden of Bowel Urgency in Patients With Ulcerative Colitis and Crohn’s Disease: A Real-World Global Study. Crohn s & Colitis 360. 6(3). otae047–otae047. 2 indexed citations

D’Haens, Geert, Silvio Danese, Bruce E. Sands, et al.. (2024). 985 EFFICACY OF MIRIKIZUMAB IN COMPARISON TO USTEKINUMAB IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: RESULTS FROM THE PHASE 3 VIVID 1 STUDY. Gastroenterology. 166(5). S–238. 2 indexed citations

Regueiro, Miguel, Monika Fischer, Peter Bossuyt, et al.. (2024). Mirikizumab Sustained Impact on Fatigue in Patients with Moderately to Severely Active Crohn’s Disease in the Phase 2 AMAG Study. Inflammatory Bowel Diseases. 31(2). 432–441. 4 indexed citations

Jairath, Vipul, Bruce E. Sands, Peter Bossuyt, et al.. (2024). OP35 Efficacy of mirikizumab in comparison to ustekinumab in patients with moderate to severe Crohn’s disease: Results from the phase 3 VIVID 1 study. Journal of Crohn s and Colitis. 18(Supplement_1). i62–i64. 20 indexed citations

Magro, Fernando, Marijana Protić, Gert De Hertogh, et al.. (2023). Effects of Mirikizumab on Histologic Resolution of Crohn's Disease in a Randomized Controlled Phase 2 Trial. Clinical Gastroenterology and Hepatology. 22(9). 1878–1888.e10. 7 indexed citations

10.

Pai, Rish K., Gert De Hertogh, Walter Reinisch, et al.. (2023). Impact of mirikizumab therapy on histologic measures of intestinal inflammation in a Phase 2 study of patients with moderately to severely active Crohn’s disease. Zeitschrift für Gastroenterologie. 61(5). e183–e184. 1 indexed citations

11.

Uzzan, Mathieu, Yoram Bouhnik, María T. Abreu, et al.. (2023). Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential Solutions. Journal of Crohn s and Colitis. 17(7). 1066–1078. 26 indexed citations

12.

Regueiro, Miguel, Monika Fischer, David T. Rubin, et al.. (2022). S834 Improvement in Fatigue With Mirikizumab Therapy Is Associated With Clinical Remission and Pain Improvements but Not With Endoscopic Response in Patients With Moderately-to-Severely Active Crohn’s Disease. The American Journal of Gastroenterology. 117(10S). e602–e603. 1 indexed citations

13.

Pai, Rish K., Gert De Hertogh, Walter Reinisch, et al.. (2021). P395 Impact of mirikizumab therapy on histologic measures of intestinal inflammation in a Phase 2 study of patients with moderately to severely active Crohn’s disease. Journal of Crohn s and Colitis. 15(Supplement_1). S404–S406. 4 indexed citations

14.

Protić, Marijana, Srdjan Marković, & Dino Tarabar. (2017). Case Report: Acute Flair of Ulcerative Colitis during Pregnancy Is Still a Major Problem. Digestive Diseases. 35(1-2). 134–138. 2 indexed citations

15.

Ben‐Horin, Shomron, Jane M. Andrews, Κωνσταντίνος Κατσάνος, et al.. (2017). Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practice. World Journal of Gastroenterology. 23(16). 2995–2995. 8 indexed citations

16.

Protić, Marijana, Frank Seibold, Alain Schoepfer, et al.. (2014). The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients. Journal of Crohn s and Colitis. 8(11). 1427–1437. 26 indexed citations

17.

Protić, Marijana, et al.. (2012). Autoimmune polyglandular syndrome type 2, alopecia universalis and Crohn's disease. Journal of Crohn s and Colitis. 7(4). 318–321. 7 indexed citations

18.

Protić, Marijana, Sonja Pavlović, Daniela Bojic, et al.. (2008). CARD15 gene polymorphisms in Serbian patients with Crohnʼs disease: genotype–phenotype analysis. European Journal of Gastroenterology & Hepatology. 20(10). 978–984. 12 indexed citations

19.

Protić, Marijana. (2005). Mechanism of diarrhea in microscopic colitis. World Journal of Gastroenterology. 11(35). 5535–5535. 34 indexed citations

20.

Protić, Marijana, et al.. (2000). Mechanism of diarrhea in microscopic colitis. Gastroenterology. 118(4). A377–A377. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact